Prelude Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

A detailed history of Prelude Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Prelude Capital Management, LLC holds 16,422 shares of TEVA stock, worth $287,385. This represents 0.02% of its overall portfolio holdings.

Number of Shares

16,422

Previous 16,328 0.58%

Holding current value

$287,385

Previous $230,000 15.65%

% of portfolio

0.02%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $1,201 - $1,635	94 Added 0.58%	16,422 $266,000
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $174,219 - $235,613	16,328 New	16,328 $230,000
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $15,876 - $20,357	-1,844 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $94,852 - $140,452	-11,068 Reduced 85.72%	1,844 $17,000
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $81,938 - $134,514	12,548 Added 3447.25%	12,912 $127,000
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $133,866 - $259,159	-16,486 Reduced 97.84%	364 $3,000
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $50,619 - $65,012	3,249 Added 23.89%	16,850 $264,000
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $36,533 - $59,695	2,504 Added 22.56%	13,601 $210,000
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $202,239 - $246,316	9,603 Added 642.77%	11,097 $239,000
Q2 2018 Aug 14, 2018	BUY	$16.77 - $24.71 $25,054 - $36,916	1,494 New	1,494 $36,000
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $603,615 - $798,669	-36,188 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $208,080 - $353,903	18,529 Added 104.93%	36,188 $686,000
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $272,125 - $568,090	17,659	17,659 $311,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Teva Pharmaceutical Industries LTD Transaction History